Ironwood Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Ironwood Pharmaceuticals

17/02/2022 14:31

* Ironwood Pharmaceuticals Inc  IRWD.OQ  reported quarterly
adjusted earnings of 27 cents​​ per share for the quarter ended
in December. The mean expectation of four analysts for the
quarter was for earnings of 35 cents per share.
    * Revenue rose 0.4% to $117.13 million from a year ago; 
analysts
expected $109.87 million. 
    * Ironwood Pharmaceuticals Inc's reported EPS for the
quarter was
25 cents​.
    * The mean earnings estimate of analysts had risen by
about 1% in
the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Ironwood Pharmaceuticals Inc shares had fallen by 5.7%
this
quarter.
    * The company reported quarterly net income of $41.37
million.
    * Wall Street's median 12-month price target for Ironwood
Pharmaceuticals Inc is $13.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 17 at 02:31 p.m.
 ​All figures in US dollars unless otherwise stated